FCM
Farallon Capital Management Portfolio holdings
AUM $21.3B
1-Year Return
23.12%
This Quarter Return
+2.95%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$12B
AUM Growth
+$2B
(+20%)
Cap. Flow
+$1.99B
Cap. Flow
% of AUM
16.6%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
107
New
26
Increased
43
Reduced
12
Closed
21
Top Buys
| 1 |
COL
Rockwell Collins
COL
|
+$387M |
| 2 |
Keurig Dr Pepper
KDP
|
+$387M |
| 3 |
MON
Monsanto Co
MON
|
+$374M |
| 4 |
LOGM
LogMein, Inc.
LOGM
|
+$202M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$182M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$307M |
| 2 |
AABA
Altaba Inc. Common Stock
AABA
|
+$244M |
| 3 |
AB InBev
BUD
|
+$164M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$163M |
| 5 |
Huntsman Corp
HUN
|
+$80.7M |
Sector Composition
| 1 | Technology | 25.94% |
| 2 | Healthcare | 17.57% |
| 3 | Communication Services | 16.49% |
| 4 | Financials | 13.71% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alnylam Pharmaceuticals
ALNY
$60.4B
| $44.1M | 0.31% |
+370,000
| New | +$44.1M |
|
52
VEON
VEON
$3.67B
| $40.9M | 0.28% |
620,040
-557,301
| -47% | -$36.8M |
|
53
NovoCure
NVCR
$1.42B
| $40.3M | 0.28% |
1,850,000
+685,000
| +59% | +$14.9M |
|
|
AVXS
54
DELISTED
AveXis, Inc. Common Stock
AVXS
| $36.3M | 0.25% |
+294,000
| New | +$36.3M |
|
|
RC
55
Ready Capital
RC
$695M
| $33.5M | 0.23% |
2,208,239
+8,232
| +0.4% | +$125K |
|
56
Galapagos
GLPG
$2.1B
| $30.8M | 0.21% |
308,260
+18,260
| +6% | +$1.82M |
|
57
Cigna
CI
$79.3B
| $30.2M | 0.21% |
+180,000
| New | +$30.2M |
|
58
CRISPR Therapeutics
CRSP
$5.26B
| $29.5M | 0.2% |
645,000
-213,602
| -25% | -$9.76M |
|
|
BMS
59
DELISTED
Bemis
BMS
| $24.5M | 0.17% |
562,500
+502,500
| +838% | +$21.9M |
|
60
Avista
AVA
$2.92B
| $20.5M | 0.14% |
+400,000
| New | +$20.5M |
|
61
Savara
SVRA
$624M
| $20.5M | 0.14% |
2,225,000
| – | – |
|
62
Hain Celestial
HAIN
$146M
| $17.5M | 0.12% |
545,000
+255,000
| +88% | +$8.18M |
|
63
Voyager Therapeutics
VYGR
$234M
| $16.7M | 0.12% |
890,000
+235,188
| +36% | +$4.42M |
|
|
EVHC
64
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $14M | 0.1% |
+365,000
| New | +$14M |
|
|
AMRN
65
Amarin Corp
AMRN
$309M
| $13.7M | 0.1% |
+228,000
| New | +$13.7M |
|
66
Intellia Therapeutics
NTLA
$1.24B
| $13.7M | 0.09% |
650,000
-490,000
| -43% | -$10.3M |
|
|
ZEAL
67
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $13M | 0.09% |
865,000
+215,000
| +33% | +$3.23M |
|
|
CCXI
68
DELISTED
ChemoCentryx, Inc.
CCXI
| $12.9M | 0.09% |
+950,000
| New | +$12.9M |
|
69
Tronox
TROX
$783M
| $12.7M | 0.09% |
688,006
+498,631
| +263% | +$9.19M |
|
|
BOLD
70
DELISTED
Audentes Therapeutics, Inc
BOLD
| $9.62M | 0.07% |
320,000
+338
| +0.1% | +$10.2K |
|
|
CBI
71
DELISTED
Chicago Bridge & Iron Nv
CBI
| $9.5M | 0.07% |
+660,000
| New | +$9.5M |
|
72
Voya Financial
VOYA
$7.43B
| $9.34M | 0.06% |
+185,000
| New | +$9.34M |
|
73
Synlogic
SYBX
$19.3M
| $9.15M | 0.06% |
+65,000
| New | +$9.15M |
|
|
AHL
74
DELISTED
ASPEN Insurance Holding Limited
AHL
| $8.72M | 0.06% |
+194,341
| New | +$8.72M |
|
75
Protagonist Therapeutics
PTGX
$3.63B
| $8.71M | 0.06% |
1,013,500
+113,500
| +13% | +$975K |
|